SUPERNUS PHARMACEUTICALS, INC. (SUPN) Operating cash flow 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$47.3MFY2025 · since FY2016: $66.8M → $47.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $47.3M | -72.5% |
| FY2024 | $172.0M | +54.8% |
| FY2023 | $111.1M | -4.9% |
| FY2022 | $116.8M | -8.1% |
| FY2021 | $127.1M | -8.1% |
| FY2020 | $138.4M | -3.3% |
| FY2019 | $143.1M | +11.0% |
| FY2018 | $129.0M | +12.5% |
| FY2017 | $114.6M | +71.6% |
| FY2016 | $66.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SUPN financial trends
SUPN RevenueSUPN Net incomeSUPN Net marginSUPN Gross profitSUPN Gross marginSUPN Operating incomeSUPN Operating marginSUPN Free cash flowSUPN Capital expendituresSUPN Return on equitySUPN Stock buybacksSUPN Dividends paidSUPN Total assetsSUPN Total liabilitiesSUPN Shareholders’ equitySUPN overview →